Gene: RAB30
Official Full Name: RAB30, member RAS oncogene familyprovided by HGNC
Gene Summary: Predicted to enable GTP binding activity and GTPase activity. Involved in Golgi organization. Located in Golgi cisterna; cis-Golgi network; and trans-Golgi network. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27650 | RAB30 Knockout cell line (HeLa) | Human | RAB30 | 1:3~1:6 | Negative | Online Inquiry |
KO27651 | RAB30 Knockout cell line (HCT 116) | Human | RAB30 | 1:2~1:4 | Negative | Online Inquiry |
KO27652 | RAB30 Knockout cell line (HEK293) | Human | RAB30 | 1:3~1:6 | Negative | Online Inquiry |
KO27653 | RAB30 Knockout cell line (A549) | Human | RAB30 | 1:3~1:4 | Negative | Online Inquiry |
RAB30 Gene Knockout Cell Lines represent a cutting-edge tool in genetic research, designed to elucidate the functional roles of the RAB30 gene through precise gene editing techniques. These cell lines have been engineered to lack functional expression of the RAB30 gene, allowing researchers to investigate its involvement in cellular processes such as vesicular trafficking, membrane dynamics, and other critical pathways that influence cell behavior and disease states.
The primary function of RAB30, a member of the RAB GTPase family, is to regulate intracellular transport mechanisms. By utilizing RAB30 Gene Knockout Cell Lines, scientists can assess the downstream effects of RAB30 deletion on various cellular functions. The knockout model provides a unique opportunity to explore alterations in endosomal trafficking and protein sorting, thereby contributing to a more comprehensive understanding of the molecular underpinnings of diseases, such as cancer and neurodegenerative disorders.
The scientific importance of these cell lines is underscored by their application in both research and clinical settings. Researchers can employ these knockout models to dissect signaling pathways, assess drug efficacy, and screen potential therapeutic agents. The insights gained from studies utilizing RAB30 knockout cells may pave the way for new intervention strategies targeting specific malignancies or genetic disorders.
What sets our RAB30 Gene Knockout Cell Lines apart from traditional approaches is their high specificity and reproducibility, achieved through validated CRISPR-Cas9 gene editing technology. This ensures minimal off-target effects and a robust model for studying gene function, presenting a significant advantage over conventional methods. Furthermore, our product is constructed under stringent quality control protocols, providing researchers with reliable tools tailored to their experimental needs.
This product is invaluable for researchers and clinicians seeking to deepen their understanding of RAB30's biological roles and its potential as a therapeutic target. The RAB30 Gene Knockout Cell Lines empower users with innovative solutions for tackling complex biological questions and advancing biomedical research.
At our company, we are committed to providing high-quality biological products backed by extensive expertise and cutting-edge technology, ensuring that our customers have the tools necessary to excel in their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.